Use reconstituted vial within 14 days
Similarly, medical studies report that new GLP-1 prescriptions have become predominantly for obesity rather than diabetes: e.g., in 20192023 only ~57% of new GLP-1 patients had T2D (down from ~65% a decade earlier) ( [27] ) ( [28] )
For many people using medications such as Ozempic, Wegovy, or Mounjaro, a new question is emerging in clinics across the United States: What happens if you want to start a family
Not every patient is a candidate, and individualized care is essential to achieving safe, sustainable outcomes
Monitoring during a BPC-157 protocol should include regular assessment of the target outcome, whether that is a functional performance metric, a validated symptom score for gut health, or imaging of a healing musculoskeletal injury
Both BPC-157 and TB-500 (thymosin 4 and derivatives) are banned at all times by WADA, and there is no therapeutic-use-exemption pathway for non-approved substances